Results 81 to 90 of about 24,825 (117)

Underinvestment, Corporate Power and Health Promotion's Moral Jeopardy. [PDF]

Health Promot J Austr
Lunnay B, Hallett J, Crawford G.
europepmc   +1 more source

Valuation effects of U.S. monetary policy tightening: The roles of foreign exposure. [PDF]

PLoS One
Fang X, Peng X.
europepmc   +1 more source

Impact of China's national drug price negotiation on pharmaceutical firms' innovation activities. [PDF]

Front Public Health
Xu H, Wang J, Zhou Q.
europepmc   +1 more source

Corporate ownership of hospitals and physician unionization. [PDF]

J Hosp Med
Bowling DS.
europepmc   +1 more source

The politicization of ESG investing shows why ESG metrics cannot be depoliticized. [PDF]

Humanit Soc Sci Commun
Chen S.
europepmc   +1 more source

Biodiversity risks and corporate innovation: Evidence from China. [PDF]

PLoS One
Lin Y, Song Z.
europepmc   +1 more source

Energy infrastructure construction and enterprises' Artificial Intelligence development: Evidence from China's ultra-high voltage transmission projects. [PDF]

PLoS One
Lin W, Guo Y, Wang B, Cheng Q.
europepmc   +1 more source

Analysis of the effects and mechanisms of carbon emission trading policies on the risk-taking behavior of high-carbon enterprises. [PDF]

Carbon Balance Manag
Tian J, Wu Z, Wang J, Peng J, Luo H, Fu S.   +5 more
europepmc   +1 more source

Assessing the investment risk: An empirical analysis of Altman's Z-score model. [PDF]

PLoS One
Ahmed KA, Fatima A, Sohail F, Jamal K.
europepmc   +1 more source